Anti‐transcriptional Intermediary Factor 1‐γ Antibody as a Biomarker in Patients With Dermatomyositis

Journal of Dermatology - United States
doi 10.1111/1346-8138.15128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Anti-Mda5 Antibody as a Potential Diagnostic and Prognostic Biomarker in Patients With Dermatomyositis

Oncotarget
Oncology
2017English

017 Immunization of Dermatomyositis-Specific Autoantigen Transcriptional Intermediary Factor (TIF1)-γ Induces Experimental Myositis in Mice

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

003 a Case of Wong-Type Dermatomyositis With Anti-Tif1-Γ Antibody

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Anti‐TIF‐1β Antibody in Dermatomyositis

British Journal of Dermatology
DermatologyMedicine
2019English

FRI0408 Neopterin as a Serological Marker of Disease Activity in Patients With Anti-Melanoma Differentiation-Associated Gene 5 Antibody Positive Clinically Amyopathic Dermatomyositis

2017English

Serum KL‐6 Level Is a Prognostic Marker in Patients With Anti‐MDA5 Antibody‐positive Dermatomyositis Associated With Interstitial Lung Disease

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2019English

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

JAMA Dermatology
DermatologyMedicine
2013English

Transcription Intermediary Factor 1γ Decreases Protein Expression of the Transcriptional Cofactor, LIM-domain-binding 1

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

SCLE and Dermatomyositis in Anti‐PD‐1 Therapy

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy